- Report
- December 2024
- 100 Pages
Global
From €5196EUR$5,950USD£4,514GBP
- Report
- August 2025
- 184 Pages
Global
From €3096EUR$3,545USD£2,690GBP
€3440EUR$3,939USD£2,988GBP
- Report
- March 2025
- 175 Pages
Global
From €3921EUR$4,490USD£3,406GBP
- Report
- August 2025
- 154 Pages
Global
From €2533EUR$2,900USD£2,200GBP
- Report
- July 2025
- 150 Pages
Global
From €5196EUR$5,950USD£4,514GBP
- Report
- December 2024
- 110 Pages
Global
From €5196EUR$5,950USD£4,514GBP
- Report
- August 2025
- 199 Pages
Global
From €3096EUR$3,545USD£2,690GBP
€3440EUR$3,939USD£2,988GBP
- Report
- August 2025
- 185 Pages
Global
From €3096EUR$3,545USD£2,690GBP
€3440EUR$3,939USD£2,988GBP
- Report
- August 2025
- 186 Pages
Global
From €3096EUR$3,545USD£2,690GBP
€3440EUR$3,939USD£2,988GBP
- Report
- August 2025
- 196 Pages
Global
From €3096EUR$3,545USD£2,690GBP
€3440EUR$3,939USD£2,988GBP
- Report
- August 2025
- 182 Pages
Global
From €3096EUR$3,545USD£2,690GBP
€3440EUR$3,939USD£2,988GBP
- Report
- August 2025
- 186 Pages
Global
From €3096EUR$3,545USD£2,690GBP
€3440EUR$3,939USD£2,988GBP
- Report
- August 2025
- 196 Pages
Global
From €3096EUR$3,545USD£2,690GBP
€3440EUR$3,939USD£2,988GBP
- Report
- August 2025
- 182 Pages
Global
From €3096EUR$3,545USD£2,690GBP
€3440EUR$3,939USD£2,988GBP
- Report
- August 2025
- 180 Pages
Global
From €3096EUR$3,545USD£2,690GBP
€3440EUR$3,939USD£2,988GBP
- Report
- May 2025
- 150 Pages
Global
From €3362EUR$3,850USD£2,921GBP
€4236EUR$4,850USD£3,680GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1092EUR$1,250USD£948GBP
- Report
- September 2025
- 270 Pages
Global
From €5109EUR$5,850USD£4,438GBP
- Report
- September 2025
- 340 Pages
Global
From €5109EUR$5,850USD£4,438GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1092EUR$1,250USD£948GBP

The insulin market is a subset of the larger endocrine and metabolic disorders drugs market. Insulin is a hormone produced by the pancreas that helps regulate the body's blood sugar levels. It is used to treat diabetes, a condition in which the body does not produce enough insulin or is unable to use it effectively. Insulin is available in both short-acting and long-acting forms, and is typically administered via injection or an insulin pump.
The insulin market is highly competitive, with a number of major pharmaceutical companies offering a variety of insulin products. These include Eli Lilly, Novo Nordisk, Sanofi, and Merck. Additionally, there are a number of smaller companies that specialize in the production of insulin, such as Biocon, Wockhardt, and Wockhardt USA. Show Less Read more